Researchers find two antibodies in common in people with long-COVID, the lingering post-infection condition that was recognised by the World Health Organization (WHO) last October. But scientists say symptoms and how many people develop the virus are still unclear. By Maayan Hoffman A sizable portion of the 370 million people infected with SARS-COV2 experience Post-Acute […] Continue reading ->
Despite a severe lack of COVID test and serological data in Africa, most people on the continent have probably already been exposed to SARS-CoV2, said the director of the influential Institute for Health Metrics and Evaluation on Thursday.  And in light of that, and the fact that COVID vaccines do not prevent infection, but rather […] Continue reading ->
Unless a future pandemic ‘instrument’ is properly financed and legally binding, it will not be able to prevent health emergencies, numerous member states told the World Health Organization’s (WHO) 150th executive board meeting on Monday. Speaking on behalf of Africa’s 47 member states, Kenya’s Dr Cleopa Mailu said there should be a “radical disruption” of […] Continue reading ->
In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older.  The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading ->
Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading ->
CAPE TOWN – South African-born US biotech billionaire Patrick Soon-Shiong launched a vaccine manufacturing plant in the country of his birth on Wednesday, aimed at producing “second generation” vaccines to address COVID-19 and other diseases. Soon-Shiong, who has made his fortune from developing successful cancer treatments, has committed an initial $195 million to NantSA – […] Continue reading ->
A fourth COVID-19 booster mRNA vaccine has proven ineffective against Omicron infection, according to preliminary research from Israel released on Monday. “Despite a significant increase in antibodies after the fourth vaccine, this protection is only partially effective against the Omicron strain, which is relatively resistant to the vaccine,” lead researcher Prof Gili Regev-Yochay, told a […] Continue reading ->